Maximum quantity allowed is 999
请选择数量
CAS RN: 129938-20-1 | 產品號碼: D4761
Dapoxetine Hydrochloride
×
![]()
×
* 以上價格已含運費關稅等但一些需要海運以及乾冰運輸的產品除外,詳情請與
當地經銷商
洽詢。
* TCI會時常優化儲存條件,儲存溫度請以在線目錄為準，敬請留意。
| 產品號碼 | D4761 |
| 純度/分析方法 | >98.0%(HPLC) |
| 分子式 / 分子量 | C__2__1H__2__3NO·HCl = 341.88 |
| 外觀與形狀（20°C） | Solid |
| 儲存條件 | Refrigerated (0-10°C) |
| 應避免的情況 | Heat Sensitive |
| 包裝和容器 | 1G-Glass Bottle with Plastic Insert （閲覽圖片） |
| CAS RN | 129938-20-1 |
| Reaxys-RN | 10603966 |
| PubChem Substance ID | 253660535 |
| Merck Index(14) | 2821 |
| MDL編號 | MFCD08272809 |
產品規格
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Nonaqueous Titration) | min. 97.0 % |
| Melting point | 179.0 to 183.0 °C |
| Specific rotation [a]20/D | +124 to +129 deg(C=1, MeOH) |
| NMR | confirm to structure |
性質
| 熔點 | 181 °C |
| 比旋光 [α]D | 125° (C=1,MeOH) |
| 溶解性（可溶於） | Methanol |
GHS
| 圖形表示 |
|
| 信號詞 | Warning |
| 危險性說明 | H302 : Harmful if swallowed. H319 : Causes serious eye irritation. H413 : May cause long lasting harmful effects to aquatic life. |
| 防範說明 | P501 : Dispose of contents/ container to an approved waste disposal plant. P273 : Avoid release to the environment. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P280 : Wear eye protection/ face protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
相關法規
運輸資料
| HS編碼* | 2922.19-000 |
Application
Dapoxetine Hydrochloride: A Short-Acting Selective Serotonin Reuptake Inhibitor (SSRI)
Dapoxetine hydrochloride is a short-acting selective serotonin (5-HT) reuptake inhibitor (SSRI), similar in structure to fluoxetine hydrochloride [F0750]. (The product is for research purpose only.)
References
- Dapoxetine hydrochloride (a review)
- Dapoxetine: a novel, fast-acting serotonin reuptake inhibitor (a review)
- Development and validation of a RP-HPLC method for the determination of dapoxetine hydrochloride in pharmaceutical formulation using an experimental design
- Simultaneous estimation and validation of Vardenafil and Dapoxetine Hydrochloride in pharmaceutical formulation by thin layer chromatographic densitometric method
- Determination of dapoxetine, an investigational agent with the potential for treating depression, and its mono- and di-desmethyl metabolites in human plasma using column-switching high-performance liquid chromatography
考研文獻
TCIMail
產品文件 （部分產品的分析圖譜無法提供，敬請諒解。）
SDS
請選擇語言。
請求的SDS不可用。
如需更多幫助，請聯繫我們 。
產品規格
檢驗報告(CoA)及其他文檔
請輸入批號
輸入的批號不正確
示例 CoA
可下載CoA示例。注：該示例可能非最新批次的CoA。
目前沒有該產品的 CoA 示例。
分析圖譜
請輸入批號
輸入的批號不正確
很抱歉，您搜索的分析圖譜無法提供。